We demonstrate that the optical response of a single Au bowtie nanoantenna can be favorably modified to increase the local intensity by a factor of 10(3) in the feed gap region when a periodic array of antennas are used. We find that the array periodicity can be used to modulate and shape the spectral emission. An analysis of the emission confirms the presence of second-harmonic generation and two-photon photoluminescence, typical of gold nanostructures, but also reveals a portion of the emitted spectrum that cannot be attributed to a single multiphoton process. Our investigations have important implications for understanding the role of resonant nanostructures in designing optical antennas for next-generation photonic technologies.

No abstract

No abstract

Quantitative second-harmonic generation imaging is employed to assess stromal collagen in normal, hyperplastic, dysplastic, and malignant breast tissues. The cellular scale organization is quantified using Fourier transform-second harmonic generation imaging (FT-SHG), while the molecular scale organization is quantified using polarization-resolved second-harmonic generation measurements (P-SHG). In the case of FT-SHG, we apply a parameter that quantifies the regularity in collagen fiber orientation and find that malignant tissue contains locally aligned fibers compared to other tissue conditions. Alternatively, using P-SHG we calculate the ratio of tensor elements (d15/d31, d22/d31, and d33/d31) of the second-order susceptibility χ2 for collagen fibers in breast biopsies. In particular, d15/d31 shows potential differences across the tissue pathology. We also find that trigonal symmetry (3m) is a more appropriate model to describe collagen fibers in malignant tissues as opposed to the conventionally used hexagonal symmetry (C6). This novel method of targeting collagen fibers using a combination of two quantitative SHG techniques, FT-SHG and P-SHG, holds promise for breast tissue analysis and applications to characterizing cancer in a manner that is compatible with clinical practice.

The worldwide use of Nile tilapia (Oreochromis niloticus Linnaeus, 1758) in aquaculture represents a somewhat unique scenario. The natural distributions and global genetic resources of tilapias are in Africa, yet the main centers of utilization for aquaculture are primarily in Asia. Within a few decades, Nile tilapia graduated from being an ‘orphan commodity’ (i.e. of interest to only resource‐poor fish farmers) to a globally traded commodity. Most aquaculture production of Nile tilapia in Asia and elsewhere has relied on a narrow genetic base. The natural genetic resources have not yet been fully documented and tapped for use in aquaculture, and many natural populations are under severe threat of irreversible change or loss. Although genetic improvement is now well underway, an important question is how the wealth of Nile tilapia wild genetic resources shall be used for the benefit of a wide range of users, at present outside Africa. This review focuses on documenting the status of Nile tilapia genetic resources (including the potential threats), providing a case for their conservation and for the judicious utilization of genetic diversity for the benefit of all stakeholders; and on analysis of the lessons learnt from a major Nile tilapia genetic improvement initiative, the genetic improvement of farmed tilapia (GIFT) project. Information about other genetic improvement efforts by means of hybridization, sex reversal and YY male technology is also presented.